PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs

Overview of attention for article published in Clinical Epigenetics, October 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 24,151 followers.

PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple #myeloma patients and overcome resistance to IMiDs: https://t.co/M4DFDpZ1lt. https://t.co/FIazL9iFcL

06 Oct 2018

Reply Repost Favourite

RT @epigen_papers: Pubmed: PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome r…

06 Oct 2018

Reply Repost Favourite

Pubmed: PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs. https://t.co/lGhRfRk7Oe

05 Oct 2018

Reply Repost Favourite

Congratulations for this collaborative paper @IGH_MTP @CNRSenLR @umontpellier @CHU_Montpellier #Universitätsklinikum Heidelberg & @NCT_HD in Clinical Epigenetics @BioMedCentral

05 Oct 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.